We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

After Court Loss, Biotech Company Removes Enzyme

Law360 (August 28, 2006, 12:00 AM EDT) -- Danisco subsidiary Genencor International Inc. announced Friday that it was withdrawing Spezyme Ethyl—an alpha amylase enzyme used in ethanol production—from the market.

The decision came only a day after a federal judge ruled that Spezyme Ethyl infringed a patent owned by Genencor’s main rival, Danish biotech company Novozymes A/S.

“We are very pleased with the decision but we are obviously annoyed by the harm the patent infringement has caused on our market for biofuel enzymes,” said Novozymes’ general counsel Kristian Merser. “It’s very satisfactory that the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.